|
Mar 7
|
Harvard Bioscience Inc (HBIO) Reports Mixed Fourth Quarter and Full Year 2023 Results
|
|
Mar 7
|
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
|
|
Mar 6
|
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
|
|
Nov 8
|
Q3 2023 Harvard Bioscience Inc Earnings Call
|
|
Nov 7
|
Harvard Bioscience Inc (HBIO) Reports Q3 2023 Earnings: Gross Margin Expands Amid Revenue Decline
|
|
Nov 7
|
Harvard Bioscience Announces Third Quarter 2023 Financial Results
|
|
Nov 6
|
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
|
|
Aug 24
|
Harvard Bioscience President Acquires 1.6% More Stock
|
|
Jun 22
|
Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
|
|
Jun 21
|
Here's Why Momentum in Harvard Bioscience (HBIO) Should Keep going
|
|
Jun 20
|
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
|